GGrantIndex
← Search

IMMUNE RESPONSES &VACCINATION MUTANT RAS &P53 PEPTIDES IN CANCER

$0M01FY2000RRNIH

Vanderbilt University, Nashville TN

Investigators

Linked publications & trials

Abstract

Determine whether cellular or humoral immunity specific to an individual patient's tumor mutant RAS or P53 oncogene products exist and if such immunity can be induced or boosted by vaccination with a synthetic peptide specific to the mutation in RAS or P53 present in a patient's tumor. Also, assess toxity form such vaccination. We are still recruiting patients for the protocol.

View original record on NIH RePORTER →